Gestational diabetes mellitus (GDM) is a serious obstetric complication that affects approximately 10% to 15% of pregnancies worldwide and is characterized by an insufficient insulin response to compensate for the insulin-resistant state of pregnancy (2, 3). This evidence concerns the gene INS and gestational diabetes.